Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_assertion type Assertion NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_head.
- NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_assertion description "[While MAL was largely unmethylated at the transcription start site (Region 1; -48 to +73 bp) in primary serous ovarian cancers, methylation of an upstream region (Region 2; -452 to -266 bp) was inversely correlated with MAL transcription in the primary cancers (R = -0.463) and ovarian cancer cell lines (R = -0.444).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_provenance.
- NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_assertion evidence source_evidence_literature NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_provenance.
- NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_assertion SIO_000772 19642140 NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_provenance.
- NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_assertion wasDerivedFrom befree-20140225 NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_provenance.
- NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_assertion wasGeneratedBy ECO_0000203 NP560399.RA12P3blQX5Eip5msay9QHLhOyPHZNqkaml8bU1UiBO3U130_provenance.